1. Home
  2. SCOR vs LSTA Comparison

SCOR vs LSTA Comparison

Compare SCOR & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo comScore Inc.

SCOR

comScore Inc.

N/A

Current Price

$6.87

Market Cap

32.8M

ML Signal

N/A

Logo Lisata Therapeutics Inc.

LSTA

Lisata Therapeutics Inc.

N/A

Current Price

$2.09

Market Cap

20.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SCOR
LSTA
Founded
1999
1980
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Misc Health and Biotechnology Services
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
32.8M
20.9M
IPO Year
2007
N/A

Fundamental Metrics

Financial Performance
Metric
SCOR
LSTA
Price
$6.87
$2.09
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$23.50
AVG Volume (30 Days)
7.3K
23.0K
Earning Date
11-04-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$358,940,000.00
$1,070,000.00
Revenue This Year
$2.01
N/A
Revenue Next Year
$1.57
N/A
P/E Ratio
N/A
N/A
Revenue Growth
0.77
N/A
52 Week Low
$4.39
$1.81
52 Week High
$10.18
$4.20

Technical Indicators

Market Signals
Indicator
SCOR
LSTA
Relative Strength Index (RSI) 50.95 55.18
Support Level $6.51 $1.96
Resistance Level $7.15 $2.10
Average True Range (ATR) 0.34 0.11
MACD 0.04 0.03
Stochastic Oscillator 68.64 92.31

Price Performance

Historical Comparison
SCOR
LSTA

About SCOR comScore Inc.

comScore Inc is a United States-based information and analytics company that measures advertising, content, and the consumer audiences of each across media platforms. The platforms it measures include televisions, mobile devices, computers, tablets, CTV devices, and movie theaters. The company generates almost all its revenue from the United States, followed by Europe, Latin America, Canada, and other regions. It provides solutions for the automotive, digital media, financial services, pharmaceutical, retail, technology, travel, and other industries.

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.

Share on Social Networks: